HTA License Conformance Analysis for ICHOM Patient Centered Outcomes Measure Set for Breast Cancer

The content of this page is being developed with the HTA committee, and is subject to further change. Editors are welcome to use this page to pick up errors in their definitions, but should not regard the analysis as final.

http://snomed.info/sct: All OK
http://loinc.org: All OK
http://unitsofmeasure.org: To be resolved

http://snomed.info/sct (SNOMED CT (all versions))

Uses

Expected Copyright

This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement
The SNOMED International IPS Terminology is distributed by International Health Terminology Standards Development Organisation, trading as SNOMED International, and is subject the terms of the Creative Commons Attribution 4.0 International Public License. For more information, see SNOMED IPS Terminology
The HL7 International IPS implementation guides incorporate SNOMED CT®, used by permission of the International Health Terminology Standards Development Organisation, trading as SNOMED International. SNOMED CT was originally created by the College of American Pathologists. SNOMED CT is a registered trademark of the International Health Terminology Standards Development Organisation, all rights reserved. Implementers of SNOMED CT should review usage terms or directly contact SNOMED International: info@snomed.org

Type of treatments ValueSet

☑

TNMPrimaryTumorVS

TNM Primary Tumor ValueSet

☑

SACQPatientComorbidityHistory

SACQ Patient's comorbidity history ValueSet

☑

ComplicationImpactVS

Impact of complication ValueSet

☑

TargetedTherapyVS

Type of targeted therapy ValueSet

☑

TherapyIntentVS

Intent of therapy ValueSet

☑

GermlineMutationVS

Germline Mutation ValueSet

☑

ReoperationReasonVS

Reasoncode of the re-operation

☑

TargetedAxillaSurgeryVS

Targeted axilla surgery ValueSet

☑

MenopausalStatusVS

Menopausal status of patient ValueSet

☑

LateralityVS

Laterality of breast cancer ValueSet

☑

InvolvedMarginsReoperationTypeVS

Re-operation due to involved margins ValueSet

☑

LocationRadiotherapyVS

The location of radiotherapy ValueSet

☑

RecommendedTreatmentTypeVS

Recommended treatment types ValueSet

☑

PatientTreatPrefVS

Patient treatment preference ValueSet

☑

RecurrenceMethodVS

Recurrence method ValueSet

☑

ChemoTherapyTypeVS

Type of chemotherapy ValueSet

☑

ProgesteroneStatusVS

Progesterone receptor status ValueSet

☑

TNMRegionalNodesVS

TNM Regional Nodes ValueSet

☑

EducationLevelVS

Education level of patient ValueSet

☑

LateralityNewCancerVS

Laterality of new cancer ValueSet

☑

ComplicationTypeVS

Type of complication ValueSet

Axilla surgery ValueSet

☑

HormonalTherapyTypeVS

Type of hormonal therapy ValueSet

☑

HER2ReceptorStatusVS

HER2 receptor status ValueSet

☑

TNMDistantMetastasesVS

TNM Distant Metastases ValueSet

☑

EstrogenStatusVS

Estrogen receptor status ValueSet

☑

GradingVS

Grading of tumor ValueSet

☑

HistologicalTypeVS

Histological type of the tumor ValueSet

☑

http://loinc.org (Logical Observation Identifiers, Names and Codes (LOINC))

Uses

Expected Copyright

This material contains content from LOINC (http://loinc.org). LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc

Staging Type for Stage Group ValueSet

☑